Calpains and cytokines in fibrillating human atria

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 1 52-1, 2002, Pages

  Goette, Andreas ^a,b   Arndt, Marco ^a,b   Röcken, Christoph ^a,b   Staack, Thorsten ^a,b   Bechtloff, Roland ^a,b   Reinhold, Dirk ^a,b   Huth, Christof ^a,b   Ansorge, Siegfried ^a,b   Klein, Helmut U ^a,b   Lendeckel, Uwe ^a,b  

^a Division of Cardiology   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Calcium; Contractile proteins; Cytokine; Fibrillation; Inflammation

Indexed keywords

CALPAIN; CALPAIN I; CALPAIN II; CALPASTATIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TROPONIN C; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; MALE; MYOFILAMENT; OPEN HEART SURGERY; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS;

EID: 0036302624     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00505.2001     Document Type: Article

References (44)

1. Myocardial cell death in fibrillating and dilated human right atria
2. Altered expression of ADAMs (a disintegrin and metalloproteinase) in fibrillating human atria
3. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation
4. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat
5. 1-ATPase activity after short episodes of atrial fibrillation in sheep
6. Angiotensin II stimulated expression of transforming growth factor-beta 1 in cardiac fibroblasts and myofibroblasts
7. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
8. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation
9. Effect of atrial fibrillation on atrial refractoriness in humans
10. Pathology of atrial fibrillation in man
11. Cytokines in heart failure: Pathogenetic mechanisms and potential treatment
12. Specific degradation of troponin T and I by μ-calpain and its modulation by substrate phosphorylation
13. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation
14. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for atrial stunning as a mechanism of thrombembolic complications
15. Cardiac biopsy in patients with primary atrial fibrillation
16. Histological substrate of atrial biopsies in patients with lone atrial fibrillation
17. Role of troponin I proteolysis in the pathogenesis of stunned myocardium
18. Electrical remodeling in atrial fibrillation: Time course and mechanisms
19. Increased expression of extracellular-signal regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
20. Antitumor necrosis factor-α improves myocardial recovery after ischemia and reperfusion
21. + exchanger in short-term atrial electrophysiological remodeling
22. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration
23. Circulating cytokines and complements in chronic heart failure
24. Tumor necrosis factor α-induced apoptosis in cardiac myocytes
25. Tumor necrosis factor αand interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum
26. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K 8644
27. Expression and activity of ectopeptidases in fibrillating human atria
28. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
29. Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation
30. Basic mechanisms in congestive heart failure. Recognizing the role of pro-inflammatory cytokines
31. Plasma levels of interleukin 2, 6, 10 and phenotypic charcterization of circulating T lymphocytes in ischemic heart disease
32. Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation
33. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study
34. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation
35. Atrial fibrillation-induced atrial contractile dysfunction: A tachycardiomyopathy of a different sort
36. Structural remodeling of the left atrial appendage in patients with chronic nonvalvular atrial fibrillation: Implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography
37. Calpain activity in fast, slow, transforming, and regenerating skeletal muscles of rat
38. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardias
39. Angiotensin transforming growth factor-β 1 and repair in the infarcted heart
40. Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers
41. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
42. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury
43. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart
44. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation